Substack | Drug Development Shouldn't Start in the Lab. It Should Start with Patients.
- Jun 30
- 1 min read
Leen Kawas traces her investment philosophy all the way back to her early days behind
a pharmacy counter, and in this Substack post she builds a clear-eyed argument for why patient experience should shape drug development from day one, not just at the clinical trial stage.
Comments